Versant Venture Capital Vi, L.P. Oyster Point Pharma, Inc. (OYST) insider trading activity

Versant Venture Capital Vi, L.P. is > 10% Shareholder of Oyster Point Pharma, Inc.. Currently has a direct ownership of 0 shares of OYST, which is worth approximately $0. The most recent transaction as insider was on Jan 03, 2023, when has been sold 2,236,888 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Versant Venture Capital VI, L.P. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Jan 03 2023	SELL Disposition due to a tender of shares in a change of control transaction	-	2,236,888 Reduced 100.0%	0 Common Stock
Feb 17 2021	SELL Other acquisition or disposition	-	325,000 Reduced 12.69%	2,236,888 Common Stock

Also insider at

BDTX

Black Diamond Therapeutics, Inc. Healthcare

ALGS

Aligos Therapeutics, Inc. Healthcare

> 10% Shareholder

IPSC

Century Therapeutics, Inc. Healthcare

> 10% Shareholder

GLUE

Monte Rosa Therapeutics, Inc. Healthcare

GRPH

Graphite Bio, Inc. Healthcare

CTNM

Contineum Therapeutics, Inc.

> 10% Shareholder

TPST

Tempest Therapeutics, Inc. Healthcare

VVC